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I. INTRODUCTION 
“Providers wrote nearly a quarter of a billion opioid prescriptions in 2013; enough 
for every American to have their own bottle of pills.”1 This high number of pills per 
American has started a tidal wave of problems that is sweeping across America. 
However, it is the drug manufacturers that are responsible for these growing problems. 
The opioid epidemic that is striking the nation is drawing serious attention and raising 
questions about what to do to solve it. While it is a nationwide problem, it has also 
hugely affected Ohio. These drugs are no longer those that can be associated with the 
common image of a ‘drug addict;’ they are being found far more frequently in high 
schools, affluent neighborhoods, and families of all races, cultures, religions and 
income statuses alike.2 The key to stopping this problem lies within the prescription 
drug community. Prescription drug manufacturers have a major influence on the 
number of pills being prescribed by doctors. In 2016, 631 million opioid pills, such as 
OxyContin, Percocet, Vicodin, Lortab, and Percodan were given out, and this number 
showed a 20.4% decrease since 2012.3 
These national problems target families and people all over the country, including 
Daniel,4 who went to high school in a small affluent town right outside Cleveland, 
Ohio. He was in high school the first time he began using pain pills. What started out 
as pain medication after an injury, quickly led Daniel to take illegal means to obtain 
more pain medication. Unbeknownst to his family and friends, this is how Daniel’s 
problem began. He went off to college after graduating high school, and that is when 
it became very apparent to his family he was having problems. After plummeting 
grades and learning he had sold nearly everything he owned, his parents had no choice 
but to bring him home. It was not until Daniel got home that his family was really able 
to understand the severity of this problem. Not only was he selling his own belongings 
                                                           
1 IMS Health, National Prescription Audit (NPATM). Cited in internal document: Preliminary 
Update on Opioid  
Pain Reliever (OPR) Prescription Rates Nationally and by State: 2010-2013. 
2 David Armstrong, 52 weeks, 52 faces, STAT (Dec. 20, 2016), 
https://www.statnews.com/feature/opioid-epidemic/obituaries/; see also Vince Grzegorek, 
Another Brutally Honest Obituary From a Family Who Lost a Loved on to a Heroin 
Overdose, SCENE & HEARD (May 5, 2017), https://www.clevescene.com/scene-and-
heard/archives/2017/05/05/another-brutally-honest-obituary-from-a-family-who-lost-a-loved-
one-to-a-heroin-overdose; see also Dan Horn and Terry DeMio, Seven Days of Heroin; This is 
what an Epidemic Looks Like, CINCINNATI.COM (Sept. 10, 2017), 
https://www.cincinnati.com/pages/interactives/seven-days-of-heroin-epidemic-cincinnati/; see 
also Jen Steer, Local man Shares Emotional Account of Daughter’s Heroin Overdose, FOX 8 
NEWS (Dec. 27, 2017), http://fox8.com/2017/12/27/local-man-shares-emotional-account-of-
daughters-heroin-overdose/. 
3 OHIO AUTOMATED RX REPORTING SYSTEM ANNUAL REPORT (2016). 
4 Busch Funeral Home, Obituary for Daniel Wolanski, (April 20, 2015), 
http://buschfuneral.tributes.com/obituary/show/Daniel-Joesph-Wolanski-102411062 (daniel 
was a high school kid, growing up in an affluent neighborhood, right outside of Cleveland, 
went to a nationally ranked high school, and would go on to attend a well-known College, 
University of Cincinnati. This story is significant, important and relevant to this topic because 
it shows that this epidemic is harming and reaching further than just our visualizations of 
“drug addicts” or people who are using drugs, but reaching into high schools, middle schools, 
colleges, and tearing apart families). 
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for pills, but he was stealing from his family and selling whatever he could get his 
hands on from the ones he loved just to get his next round of pills.5 With the help of 
his family, Daniel agreed to go to a rehabilitation facility and get the help he so 
desperately needed.  
After completing his program, he stayed clean for a period of time, but eventually 
fell right back into his old habits, except this time, it became deadlier because the pills 
were no longer affordable. Daniel turned to heroin, a much cheaper and stronger 
option, and it was not until his first overdose that his family realized the true battle he 
had ahead of him. Daniel was denied rehabilitation treatment the next time around 
because health insurance refused to pay and the cost was far more than the family 
could afford out of pocket.6 
Unfortunately for Daniel, this was happening at a time when heroin was being 
mixed and cut with a new drug called fentanyl, a much stronger drug than heroin and 
usually kept quiet when it is mixed in with heroin. Shortly thereafter, when Daniel 
was only 24 years old, he was found dead in his apartment, and it was determined that 
this occurred from an accidental overdose of heroin. This is unfortunately the tragic 
yet common ending we are seeing in today’s society. What started out as prescription 
pills for an injury, eventually lead to the untimely death because of addiction. 
The opioid epidemic that Ohio is faced with today is taking the lives of people 
across all age ranges.7 Between 2014 and 2015, Ohio had the greatest number of opioid 
related deaths in the nation – with 1 in every 14 deaths from opioids in the United 
States occurring in the state.8 With these alarming numbers, states like Ohio, that are 
                                                           
5 NATIONAL INSTITUTE ON DRUG ABUSE, Principles of Drug Abuse Treatment for Criminal 
Justice Populations – A research-based guide, (“Individuals who use illicit drugs are more 
likely to commit crimes, and it is common for many offenses to be committed by individuals 
who had used drugs or alcohol prior to committing the crime, or who were using at the time of 
the offense”), https://www.drugabuse.gov/publications/principles-drug-abuse-treatment-
criminal-justice-populations/introduction. 
6 AMERICAN ADDICTION CENTERS, Heroin Addiction and Treatment, (rehabilitation from 
heroin addiction uses medical detox, however, most heroin users want to be free of drugs upon 
arrival and tend to rush the process, causing a relapse, or they will complete the medically 
assisted detox, but have no way of dealing with the addiction once they leave treatment, and 
then end up relapsing again), https://americanaddictioncenters.org/heroin-
treatment/#The%20Best%20Way%20to%20Treat%20Heroin%20Addiction (last updated 
Sept. 4, 2018). 
7 Elizabeth Llorente, Opioid Addiction Crisis spurs brutal Candor in Obituaries, FOX NEWS 
(May 14,2017), (a 23-year-old man from Staten Island, New York dies from an overdose), 
http://www.foxnews.com/health/2017/05/14/opioid-addiction-crisis-spurs-brutal-candor-in-
obituaries.html; see also Shelly Bradbury, PITTSBURGH POST-GAZETTE (May 4, 2017) (an 11 
year-old girl dies from a heroin overdose), http://www.post-
gazette.com/news/overdosed/2017/05/04/11-year-old-girl-overdoses-heroin-Beechview-
Pittsburgh-Narcan/stories/201705040162; see also Pat Grossmith, Heroin Overdoses take 
Their toll in NH’s Largest City, UNION LEADER NEW HAMPSHIRE (Sept. 23, 2015), (the oldest 
fatality due to a heroin overdose was a 51-year-old man), 
http://www.unionleader.com/Heroin_overdoses_take_their_toll_in_NHs_largest_city_ (all of 
these examples show the significance of this epidemic. It is not only affecting those we 
consider “drug addicts,” but it is ravaging through the young and the old alike, all across the 
country). 
8 THE HENRY J. KAISER FAMILY FOUNDATION OVERDOSE DEATHS, (2014-2015); see also 
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being hit hardest with this problem, are looking for the best solutions to decrease these 
numbers. Ohio can be found at the top of that list, among other states, aggressively 
looking for ways to combat this terrible but growing problem. 
On May 31, 2017, Ohio Attorney General Mike DeWine decided to take a step in 
the right direction of fighting the epidemic. DeWine brought the first of many lawsuits 
against five top drug pharmaceutical companies.9 The five companies are, Purdue 
Pharma, Teva Pharmaceutical Industries, Cephalon, Inc., Janssen Pharmaceuticals, 
and Endo Health Solutions Inc.10 There are several counts being raised against the 
pharmaceutical companies, but only the counts for deceptive marketing practices are 
relevant for this Note.11 This charge is particularly important here because Attorney 
General DeWine states that these deceptive marketing practices are one of the leading 
causes of this serious opioid epidemic.12 This lawsuit has in turn prompted several 
other states to follow suit.13 The trend of bringing these lawsuits shows the willingness 
of states to recognize the problem and the want of these states to hold the correct 
entities accountable.14 New York Attorney General Eric Schneiderman stated, “For 
millions of Americans, their personal battle with opioid addiction did not start in a 
back alley with a tourniquet and syringe, they got hooked on medicine they were 
prescribed for pain or that they found in a medicine cabinet.”15 With law suits 
becoming more prevalent, it is showing the willingness of states to accept and want to 
hold those who are responsible accountable: the big drug pharmaceutical companies. 
In doing so, any entity bringing a lawsuit will have to overcome an exception, that 
exists under Products Liability Law, the Learned Intermediary Doctrine. 
Under Federal and State law, there is an exception that exists, called the Learned 
Intermediary Doctrine. This exception is one which can absolve the drug 
manufacturers of liability from any misconduct that might be found and transfer that 
                                                           
OHIO DEPARTMENT OF HEALTH, Drug Overdose Report  (in 2013, Ohio had 2,110 deaths 
unintentional drug overdoses), https://www.odh.ohio.gov/-
/media/ODH/ASSETS/Files/health/injury-prevention/odhnews-
2013DrugOverdoseData.pdf?la=en. 
9 Complaint, State of Ohio v. Purdue Pharma, et al., No. 17CI000261.  
10 Id. 
11 Complaint at 66, State of Ohio v. Purdue Pharma, et al., No. 17CI000261. 
12 Id.  
13 Colin Dwyer, Ohio Sues 5 Major Drug Companies For ‘Fueling Opioid Epidemic’, NPR 
THE TWO WAY (May 31, 2017) (Ohio followed Alabama in filing a law suit), 
https://www.npr.org/sections/thetwo-way/2017/05/31/530929307/ohio-sues-5-major-drug-
companies-for-fueling-opioid-epidemic; see also Jackie Borchardt, Ohio Opioid Lawsuit 
against 5 Pharma Companies: 6 Things to Know, CLEVELAND.COM (May 31, 2017) (Cherokee 
nation in Oklahoma also followed Ohio’s lead in filing a law suit), 
http://www.cleveland.com/metro/index.ssf/2017/05/ohios_opioid_lawsuit_against_5.html. 
14 Yuki Noguchi, 41 States to Investigate Pharmaceutical Companies Over Opioids, NPR THE 
TWO WAY (September 19, 2017) 
https://www.npr.org/sections/thetwoway/2017/09/19/552135830/41-states-to-investigate-
pharmaceutical-companies-over-opioids. 
15 Id. 
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liability to any treating physician.16 This exception is extremely relevant to this topic 
because it is the way many drug manufacturers were able to avoid being held 
responsible in the past. This Note proposes that with the current pending lawsuit in the 
State of Ohio, an exception to the Learned Intermediary Doctrine should be 
introduced. This Note will begin with a discussion of opioids and how these drugs 
have become such an aggressive problem in a very short amount of time in Ohio. Part 
II will talk about the role the government can play and the role the drug manufacturers 
have played and continue to play in the availability of opioids. It will discuss the effect 
these drug pharmaceutical companies have had on this problem and have had in 
increasing this problem. Part II will also discuss why this is a problem and why this 
problem matters. Further, it will talk about the steps that have already been taken by 
the Ohio Legislature to combat the opioid problems. Finally, it will delve into a 
discussion of what this current lawsuit means for fighting and decreasing the opioid 
problem and how it will directly affect the heroin epidemic in Ohio.  
II. BACKGROUND 
While this is a national problem, Ohio has been one of many states hit hard by this 
problem.17 In 2010, Ohio declared a public health emergency due to rising overdose 
deaths.18 “In 2016, unintentional drug overdoses caused the deaths of 4,050 Ohio 
residents, which was a 32.8% increase compared to 2015.”19 Although prescription 
opioid-related deaths have declined again, from 667 in 2015 to 564 in 2016,20 the 
damage from the prescription pills has already been done and continues to ravage 
through the most unsuspecting homes and families. According to a study conducted 
by the Center for Behavioral Health Statistics and Quality, in August of 2013, three 
out of four new heroin users reported first abusing prescription opioids before 
beginning to use heroin.21 While these unintentional drug overdoses include heroin,22 
the lawsuit brought by the state of Ohio relates the heroin epidemic directly to the 
misrepresentation of the effects of treating chronic pain with opioid pain killers.23 The 
lawsuit intends to hold the drug manufacturing companies liable for these 
misrepresentations that were made, which in turn lead to the heroin epidemic that is 
faced by so many today. 
                                                           
16 Ohio Rev. Code Ann. §2307.76(C) (West 1988). 
17 AMERICAN ADDICTION CENTERS, supra note 6. 
18 Ohio Attorney General Complaint against Pharmaceutical Companies: The State of Ohio is 
suing 5 major drug pharmaceutical companies for allegedly misrepresenting their products and 
for false advertising, as a violation of the law under the products liability law in Ohio, and 
under Fraud in Ohio. 
19 OHIO DEPARTMENT OF HEALTH, Drug Overdose Report (2016). 
20 Id. 
21 Pradip K. Muhuri Et Al., Association of Nonmedical Pain Reliever Use and Initiation of 
Heroin Use in the United States, SAMHSA (Aug. 2013), 
https://www.samhsa.gov/data/sites/default/files/DR006/DR006/nonmedical-pain-reliever-use-
2013.htm. 
22 Id. 
23 Complaint at 29, State of Ohio v. Purdue Pharma, et al., No. 17CI00026.  
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This section will begin with a brief discussion of opioids and what they are, the 
epidemic that is happening, and why it is important for the government to step in and 
take action. Next, there will be a discussion on the main role the drug manufacturers 
play in this epidemic. Also, this section will discuss the steps taken to try and hold 
these pharmaceutical companies liable. Finally, it will end with why the proposed 
solution is the best way to begin to get this epidemic under control. 
A. What Are Opioids? 
Opioids are a class of drugs that are usually taken for pain relief.24 There are natural 
opioids and then there are manmade synthetic opioids.25 Natural opioids come from 
the poppy plant, while synthetic opioids are created in a lab.26 Heroin, fentanyl and 
OxyContin are the three most commonly known synthetic opioids because they are 
manmade as opposed to being natural.27 “Prescription opioids are powerful pain-
reducing medications that include prescription oxycodone, hydrocodone, and 
morphine.”28 Opioids work by interacting with the opioid receptors that are on nerve 
cells in the body and brain. People who take opioids for long periods of time are known 
to have a higher risk of becoming addicted to the pills.29 These opioid addictions 
quickly lead to heroin addictions because heroin is more readily available.30 Heroin is 
also far less expensive than any prescription opioids that individuals take.31 Heroin is 
also considered to be a better option because users and addicts no longer have to go to 
their doctor to get a prescription.32 The effects that opioids have are clear, but it is not 
always clear why these drugs are such a danger and so harmful to many people in 
society. 
                                                           
24  NATIONAL INSTITUTE OF DRUG ABUSE, Opioids, (Nov. 2018), 
https://www.drugabuse.gov/drugs-abuse/opioids. 
25 Casa Palmera Staff, What Drugs are Opiates?, CASA PALMERA (Nov. 17, 2016), 
https://casapalmera.com/blog/what-drugs-are-opiates/. 
26 Id. 
27 Id. 
28 U.S. FOOD AND DRUG ADMINISTRATION, Opioid Medications, U.S. DEP’T HEALTH 
AND HUM. SERVICES (last updated June 14, 2018), 
https://www.fda.gov/Drugs/DrugSafety/InformationbyDrugClass/ucm337066.htm. 
29 NATIONAL INSTITUTE OF DRUG ABUSE, Opioids https://www.drugabuse.gov/drugs-
abuse/opioids. 
30 OHIO PRESCRIPTION DRUG ABUSE TASK FORCE; OHIO SUBSTANCE ABUSE MONITORING 
NETWORK (2008); see also AMERICAN SOCIETY OF ADDICTION MEDICINE (“94% of respondents 
in a 2014 survey of people in treatment for opioid addiction said they chose to use heroin 
because prescription opioids were ‘far more expensive and harder to obtain.’”), 
https://www.asam.org/docs/default-source/advocacy/opioid-addiction-disease-facts-
figures.pdf. 
31 OHIO PRESCRIPTION DRUG ABUSE TASK FORCE; OHIO SUBSTANCE ABUSE MONITORING 
NETWORK, supra note 30. 
32 Id. 
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1. Why Are They Harmful? 
Opiates are so harmful because of the way they interact with the brain. Opiates 
create endorphins in the brain, which in turn, lead to the user experiencing a rush of 
emotions.33 This rush of emotions is due to endorphins releasing dopamine, what is 
often known as the ‘feel-good’ emotion.34 This process does not become an issue 
unless these drugs are taken over a long period of time.35 The brain eventually stops 
producing endorphins naturally, so once the drugs are no longer being taken, the user 
no longer experiences those positive feelings and emotions.36 Without taking the 
drugs, the dopamine levels in the brain drop significantly, so the person taking the 
drugs is not experiencing this rush of emotion anymore.37 “The body quickly builds 
up a tolerance to opioids, so it takes more and more of the drug to create the same 
pain-relieving and euphoric effects.”38 Dr. Nora Volkow compared the effects of 
taking opioids with bad steering, “Your steering wheel does not work properly. So not 
only are you actually accelerating with intense desire and motivation to get the drug, 
you are not able to self-regulate and say, ‘If I take the drug, I will end up in jail.’”39 
This analogy helps to explain the dependency, because the brain is no longer 
producing these endorphins. A person who is addicted will do anything just to have 
that experience again, without considering the consequences.40 The reactions that 
occur in the brain can help explain why people turn from opioids to heroin. 
2. What Is Heroin, and Where Does it Come From? 
The drug heroin is at the heart of this epidemic and is bringing light to this 
epidemic, so it is important for this Note to explain the role of heroin. Heroin is an 
opioid drug made from morphine.41 Heroin can come in different forms and can be 
ingested in different ways, but the main way people use heroin is by injecting it with 
                                                           
33 Michael’s House, Why Are Opiates so Addictive? (2017), 
http://www.michaelshouse.com/opiate-rehab/why-are-opiates-so-addictive/. 
34  Katelyn Newman, A Personal Look at a National Problem, US NEWS AND WORLD REPORT 
(May 18, 2017), https://www.usnews.com/news/national-news/articles/2017-05-18/the-opioid-
epidemic-a-personal-look-at-a-national-problem. 
35 Id. 
36 Id. 
37 Newman, supra note 34. 
38 Id. 
39 The Associated Press, Science Say: Why are Opioids so Addictive?, 
https://www.apnews.com/7615878f9f40487593d99f02e68d96ee/Science-Says:-Why-are-
opioids-so-addictive? 
40 Michael’s House, supra note 33. 
41 NATIONAL INSTITUTE ON DRUG ABUSE, What is Heroin? (2018) 
https://www.drugabuse.gov/publications/drugfacts/heroin; see also Medline Plus, Morphine, 
U.S. NATIONAL LIBRARY OF MEDICINE (June 15, 2017), (morphine is used to treat severe pain, 
and only used when there is no other way to treat the pain, morphine is highly regulated by the 
doctor or physician prescribing it because of how strong it is and how many side effects it 
causes), https://medlineplus.gov/druginfo/meds/a682133.html#why. 
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a syringe.42 The effects of heroin are very similar to that of the effects of prescription 
drug use; people using heroin typically report a feeling of euphoria.43 Euphoria results 
because heroin affects the brain the same way prescription drugs do, which is binding 
to the opioid receptors in order to increase the feelings involved with pain and 
pleasure.44  
Heroin is not a drug that is prescribed by doctors, it is a drug that is found on the 
streets. More commonly, it is known to be found on the dark net’s “black market.” 
The dark net “is a constellation of sites and services that can be accessed through a 
special browser, which routes online traffic so it’s much more difficult to identify 
where it originally came from.”45 In July 2017, one of the largest online black market 
drug websites, known as AlphaBay, was taken down by the FBI.46 This website was 
being run not only nationally, but internationally, and was housing more than 250,000 
listings for illegal drugs.47 It was estimated that previous to AlphaBay being shut 
down, there were about 238 vendors advertising for the sales of heroin.48 While these 
type of online black market sites are very common, there are also physical places that 
people can go to obtain drugs illegally. For example, in August 2017, a medical clinic 
was closed in California for sending dangerous and addictive pills to the black 
market.49 While these are only a few examples, instances like these are happening all 
over the United States and even worldwide.50 
These kinds of statistics beg the question: how are these pills, which a patient needs 
a prescription to obtain, so readily available on the black market? Generally, there is 
one term that can describe this influx of prescription pills – diversion – which is most 
common at the patient level.51 Diversion at the patient level consists of patients who 
                                                           
42 Id.  
43 Id. 
44 Id.; see also NATIONAL INSTITUTE ON DRUG ABUSE, What are the immediate effects of heroin 
use? (Jan. 2018), https://www.drugabuse.gov/publications/research-reports/heroin/what-are-
immediate-short-term-effects-heroin-use (abusers report a “rush” feeling, and this “rush” 
feeling generally controls how much of the drug is taken in by the user and how quickly they 
experience the rush). 
45 Kif Leswing, The FBI just took down AlphaBay, Online Black Market for Drugs, BUSINESS 
INSIDER (Jul. 20, 2017), http://www.businessinsider.com/alphabay-online-black-market-taken-
down-silk-road-2017-7. 
46 Id. see also Joseph Goldstein, Arrest in U.S. Shuts Down a Black Market for Narcotics (Oct. 
2, 2013), (Silk Road was another website run on the dark net, was home to more than 100,000 
customers and was also responsible for the selling of black market drugs), 
https://www.nytimes.com/2013/10/03/nyregion/operator-of-online-market-for-illegal-drugs-
is-charged-fbi-says.html. 
47 Id. 
48 Id. 
49 Thom Mrozek, UNITED STATES ATTORNEY’S OFFICE; CENTRAL DISTRICT OF CALIFORNIA 
(Aug. 3, 2017), https://www.justice.gov/usao-cdca/pr/operators-bogus-medical-clinics-
charged-conspiracy-divert-massive-amounts-prescription. 
50 Leswing, supra note 45. 
51 Id. 
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once needed pain medication but are no longer in need of it and are sitting on pills, 
family members who find the pills and dispose of them, or patients who do not actually 
need the pain medication but are “doctor shopping.”52 Doctor shopping is a commonly 
used term today to describe a situation where a patient will go from doctor to doctor, 
trying to get a prescription for pain medication filled.53 Once they have obtained the 
prescription, they sell it.54 As discussed below, part of stopping the epidemic is 
stopping the flow of prescription drugs illegally onto the black market. 
3. Why This Issue is Important to the Government 
This problem is important to the government because it is now not only affecting 
adults, but it is also reaching younger individuals each and every year. “After 
marijuana and alcohol, prescription drugs are the most commonly misused substances 
by Americans age 14 and older.”55 The problems with addiction are soaring to 
unbelievable heights. While this is a vast problem throughout the United States, it 
would be best dealt with on the state level so that each state can make adjustments 
based on the specific problem in that state. There have been several attempts to remedy 
the problem, but nothing has been as influential as going directly to the source of the 
problem: holding the drug manufacturing companies, those responsible for the 
prescription drugs in the first place, accountable.  
Specifically in Ohio, in 2015, House Bill 4 was passed, giving broader access to 
the drug Naloxone.56 Naloxone is a drug known to reverse the effects from an opioid 
overdose, as long as it is dispensed in time.57 A survey taken counting the 
administration of Naloxone found that there were about “11 administrations per day 
of the drug in 2003, and about 29 administrations of the drug per day in 2012.”58 There 
is a clear correlation between the increase in the administration of naloxone and the 
increase in overdoses. Naloxone’s main use today is for the treatment of an overdose 
and to help reverse an overdose.59 But, as previously noted, the overdose deaths have 
only continued to rise.60 Even though Naloxone is helping to reverse specific 
incidences of overdoses, it is not substantially decreasing the overdoses, further 
                                                           
52 Eric Boodman, Opioid Crisis Fueled by Prescriptions from Family Doctors and Internists, 
STAT (Dec. 14, 2015), https://www.statnews.com/2015/12/14/opioid-crisis-fueled-
prescriptions-family-doctors-internists/. 
53 Id. 
54 Id. 
55 NATIONAL INSTITUTE ON DRUG ABUSE FOR TEENS, Prescription Drugs, (March 2017), 
https://teens.drugabuse.gov/drug-facts/prescription-drugs. 
56 Ohio House Passes Legislation Expanding The Use of Naloxone | The Ohio House of 
Representatives. 
57 Id. 
58 OHIO MENTAL HEALTH & ADDICTION SERVICES, Naloxone Administration in Ohio 2003-
2012 (2012), http://mha.ohio.gov/Portals/0/assets/Research/Reports/2013-no2-naloxone-
epidemiological%20report.pdf. 
59 Leswing, supra note 45. 
60 Dwyer, supra note 13.   
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illustrated by the continuing rise in annual overdose deaths.61 This is just furthering 
the need for the government to step in and help. 
A Sheriff in Butler County has recently refused to allow his officers to carry 
Naloxone.62 Specifically, Sheriff Richard K. Jones, will not allow his officers to carry 
Naloxone due to the expense of the drug and due to the amount of repeated 
administration to the same individuals.63 This has come across to many in the media 
as shocking because of the lives that Naloxone has helped save, however, Jones insists, 
“all we’re doing is reviving them, we’re not curing them.”64 This is a belief that is held 
by many who are skeptical of the increased availability of Naloxone.65  
State governments, as well as the federal government, acknowledge that there is a 
growing problem, but none of the solutions proposed have gone far enough to put a 
significant halt on this epidemic we are seeing, as the overdose deaths are still steadily 
increasing.66 For this reason, there needs to be stronger options in order to stop this 
epidemic from increasing. 
4. The Role Of The Food And Drug Administration 
The Food and Drug Administration (“FDA”), created in 1848, is the oldest 
consumer protection agency within the United States Government.67 The FDA was 
broadly known as a consumer protection agency, much of how we think of it today, 
but it did not have only one specific area of focus.68 As the times change throughout 
the nation, the FDA changes along the way.69 Today, however, the FDA’s drug review 
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process ensures that drugs undergo very extensive safety, quality, and effectiveness 
evaluations before they are able to be sold to the public on the market.70 
Another reason it is important to the government is because the FDA is in charge 
of allowing these kinds of drugs into society, as well as determining the guidelines 
and precautions for certain drugs.71 The mission of the FDA is to protect the public 
health by assuring safety, among other things, of human and veterinary drugs.72 
Further, in 2016, the FDA stated that opioids should only be used to treat pain as a last 
resort, which was the opposite of what drug manufacturers were advertising.73 Since 
these drugs fall under the control of the FDA, which is a governmental agency, that is 
another reason the government is, and should be, involved in this growing problem. 
B. What Role Are Drug Pharmaceutical Companies Playing? 
The role drug pharmaceutical companies play in this problem is obvious: 
pharmaceutical companies have played a vital role in the increase of opioid related 
overdoses across the country.74 Drug pharmaceutical companies have been falsely 
reassuring and representing not only to those in the medical field, but also to patients 
directly, that opioid pain relievers are safe to use for chronic pain, without risk of 
addiction.75 As alleged in the lawsuit by Ohio Attorney General, Mike DeWine, each 
of the drug manufacturing companies have been promoting the utilization of opioids 
for chronic pain through their sales representatives.76 Even after the problems were 
made public and continued to surface, DeWine alleges there was never an attempt to 
correct the falsely given information and that the drug pharmaceutical companies 
simply did nothing.77 These companies increased their budget, spending, and the time 
their drug representatives were spending with doctors.78 These practices have been 
going on since the late 1990s and have led to the epidemic we are faced with today.79 
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With this, several states are starting to point to the drug manufacturing companies as 
the ones to blame, and rightfully so.80 While other options have been tried, and have 
failed, this is one more attempt to get this epidemic under control. 
Recently, in September 2017, “41 state attorneys general announced they were 
expanding their investigation into companies that manufacture and distribute opioid 
pain killers.”81 Ohio, specifically, brought a lawsuit seeking damages from five major 
pharmaceutical companies that manufacture opioid pain pills.82 This lawsuit is seeking 
damages for the pain and suffering, loss of life, and overall punitive damages for the 
negative effects of the pharmaceutical companies’ advertising misrepresentations.83 
However, this is not the first time many of these companies are being questioned or 
even engaging in settlements for their misrepresentations.84 Though there have been 
several settlements, the pattern of misleading advertising and false representations has 
not ceased.85 
In the past, Cephalon, one of the drug manufacturing companies named in the 
lawsuit by the state of Ohio, pled guilty to a violation of the Federal Food, Drug and 
Cosmetic Act (“FDCA”) for misleading the promotion of three (3) drugs.86 Part of this 
misleading promotion that Cephalon was doing involved the drug Actiq. The company 
ordered sales representatives to try and convince doctors to use the drug for certain 
unapproved uses.87 The manufacturing company agreed to pay $425 million for the 
violation of the FDCA,88 all the while still continuing to do what it pled guilty for in 
the past.89 While the company ceased to use that sales strategy with Actiq after the 
settlement occurred in 2003, Cephalon was still pushing for the long-term use of 
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opioids to treat chronic pain. This exemplified how a settlement did not deter the 
behavior.90 
Purdue Pharma also reached a settlement agreement in federal court in the Western 
District of Virginia, paying upwards of $600 million in fines for misleading regulators, 
physicians, and patients about the risks that are associated with taking OxyContin.91 
Specifically, Purdue Pharma underestimated and underreported the “risk of addiction 
and the drug’s potential to be abused.”92 While these are only two examples, it is clear 
that these pharmaceutical companies have been aware and put on notice in the past 
that their misleading advertisements and misrepresentations have caused serious harm. 
This demonstrates the need for a more aggressive way of handling these companies.  
Furthermore, in the past it has been hard for individuals to hold pharmaceutical 
companies responsible for the adverse effects they were receiving due to the use of 
opioids.93 Generally, a state is going to be more sympathetic because a state can never 
be to blame for abusing pills, whereas individuals can be.94 In many instances, people 
perceive that the abuse of opioids by the user as his or her problem because the user 
did not appropriately use the medication and thus caused their own problems.95 This 
belief makes it very difficult to show the pharmaceutical companies’ responsibility 
and the role the pharmaceutical companies are actually playing.96 Lars Noah, a 
professor of law at the University of Florida, has stated, “doctors, not consumers, were 
the ones targeted by the aggressive marketing campaigns undertaken by 
pharmaceutical companies, so it can be difficult to link consumer deaths with 
aggressive marketing.”97 This will be discussed later in this Note, but this is essentially 
the reasoning behind the Learned Intermediary Doctrine since doctors are generally 
the ones being targeted by these pharmaceutical companies. 
1. Drug Representatives Provide Information to the Medical Community 
Drug representatives are employed by pharmaceutical companies to sell products, 
and they are also in charge of educating and informing physicians about their 
products.98 Drug representatives also work on a commission basis, so the incentive to 
get a physician to purchase from them, over their competitors, goes beyond simply 
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promoting their products.99 “These reps help to influence the physicians to prescribe 
their specific drugs to the physician’s patients.”100 This also means that these drug 
representatives are giving the physicians the same information provided to the drug 
representatives about their own products, which is provided to them by their own 
companies.101 If the pharmaceutical companies are giving out information that is 
deceptive, that means their drug representatives are giving out that same misleading 
information to the physicians.102 As alleged in the Ohio lawsuit, all of the 
pharmaceutical companies were using deceptive advertising measures to get doctors, 
as well as patients, to believe these pills were safe for long-term use when in fact they 
were not.103 These drugs were being pushed in the face of the medical community as 
a first option when in fact the FDA was pushing for these drugs to be used merely as 
a last resort.104 The drug representatives are also responsible for getting physicians to 
choose their company and their drugs over their competitors.105 It is no longer an easy 
task to get that job done, so it requires these representatives to get more creative in 
their selling tactics.106 Selling tactics can and do involve making their specific product 
more appealing to the physician than that of their competitor.107 Misleading 
information often comes from the need to make the product more appealing, more 
reliable, or better than that of the competitor. 
However, the medical community still relies entirely on the information provided 
by the drug manufacturing companies’ drug representatives, so these creative selling 
tactics were simply just a way to overshadow the drug representatives putting their 
financial goals over their responsibility and duty owed to their consumers.108 One 
study found that, in 2012, the pharmaceutical industry in the United States spent more 
than $27 billion on drug promotion and more than $24 billion of that overall spending 
went to marketing specifically to physicians.109 The dynamic between drug 
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pharmaceutical companies due to this want and need to sell their product over others 
has raised questions over the years about whether or not this is in fact ethical. 110 
Attorney General DeWine also addresses the issue of “Key Opinion Leaders 
(“KOLs”).”111 These are groups of doctors who are paid by the drug companies to be 
consultants on behalf of the drug companies and their products.112 Often times, these 
KOLs are invited to speak at continuing medical education (CME) conferences, which 
are required for those in the medical field.113 Specifically, “KOLs have written, 
consulted on, edited, and lent their names to books and articles supporting chronic 
opioid treatment.”114 This becomes problematic because doctors are relying on the 
information given by their peers as KOLs, when in fact, the KOLs’ support of the 
drugs is due to receiving payments instead of actually promoting the health and well-
being of patients.115 This is similar to the paid endorsements we see each and every 
day with athletes. They are promoting the product because they are being paid to do 
so, not because they truly believe that the product is the best one on the market. 
Another example we see of this is with lobbying within the government. Lobbyists are 
fighting for their own interests, not because the interest they want is for the greater 
good. The analogy is simple yet frightening. It has become even more obvious that 
there is a problem with the relationship between drug representatives, drug 
pharmaceutical companies, and physicians; it is time something is finally done. 
However, with such challenging allegations already set forth, states are even further 
challenged to try to hold drug pharmaceutical companies liable due to an exception 
written within products liability law. 
C. The Learned Intermediary Doctrine 
Products liability law nationally, as well as in the state of Ohio, allows consumers 
to bring a claim against a company or a manufacturer for injury or death resulting from 
the way the product was designed or made, lack of warning, or lack of warranty.116 
While products liability laws apply to just about all products on the market, these laws 
have recently been expanded to include medications as well as medical devices.117 
However, when it comes to medical drugs and medications, there is a special exception 
that exists when it comes to holding drug manufacturers liable for prescription 
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drugs.118 This exception is known as the Learned Intermediary Doctrine.119 The 
Learned Intermediary Doctrine has been recognized for almost 50 years and is now 
recognized and applied in almost every jurisdiction nationwide.120 The Learned 
Intermediary Doctrine was first recognized in case law.121 The case is from the 8th 
Circuit in 1966, Sterling Drug, Inc. v. Cornish, where an action was brought against a 
drug manufacturer for eye damage, and the plaintiff alleged that the damage was due 
to the drug that was being taken.122 The issue before the court was to determine 
whether the drug manufacturer had a duty to warn the doctor of the potential side 
effect of the drug.123 The lower court ultimately found that drug manufacturer did have 
a duty to warn the doctor since they were aware of the potential side effect of this 
drug.124 The court stated, 
  
In this case, we are dealing with a prescription drug rather than a normal 
consumer item. In such a case the purchaser’s doctor is a learned 
intermediary between the purchaser and the manufacturer. If the doctor is 
properly warned of the possibility of a side effect in some patients and is 
advised of the symptoms normally accompanying the side effect, there is an 
excellent chance that injury to the patient can be avoided.125 
 
The learned intermediary doctrine applies to manufacturers who normally would 
owe a duty to the consumer but instead are precluded from liability because the 
“learned intermediary” or the general physician has been given adequate warning 
about the consequences.126 This exception exists specifically when it comes to medical 
drugs because a physician is said to be in the best position to discuss their patients’ 
needs and to give them the necessary warnings about prescriptions and treatment 
options associated with them.127 However, this again causes a huge problem that this 
exception does not cover, which is when intentional incorrect information is being 
provided to the physician. As shown in the examples stated above, Cephalon and 
Purdue Pharma were able to reach settlements instead of properly being held 
accountable for their misrepresentations.128 
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The Ohio Supreme Court held in Tracy v. Merrell Dow Pharmaceuticals Inc., that 
“the physician has the duty to know the patient’s condition as well as the qualities and 
characteristics of the drugs or products to be prescribed.”129 In this case, the Estate of 
Larry Tracy sued Merrell Dow Pharmaceuticals for the death of Tracy and alleged that 
it was due to a known side effect of the Nicorette.130 The Court found that the physician 
in this case was participating in the study and was aware of the potential side effects 
as well as the potential effect that they would have on certain patients.131 Because the 
physician was aware of the potential side effects, it was enough to establish him as the 
learned intermediary, and thus, shifting the blame from the drug company to the 
physician.132 In Ohio, manufacturers of prescription drugs are precluded from liability 
for failure to instruct or warn consumers so long as they instruct and warn the 
physician that is responsible for prescribing the medication to the consumer.133 There 
is no line drawn in Ohio that determines whether or not the information being provided 
must be accurate but only that if the information is provided, the drug companies 
cannot be held liable.134 
The Learned Intermediary Doctrine becomes an issue when specifically trying to 
hold drug companies liable because they are able to pass along the liability.135 In Tracy 
v. Merrell Dow Pharmaceuticals Inc., the Ohio Supreme Court refused to allow 
recovery for a death that resulted from nicotine chewing gum that was prescribed by 
the family doctor.136 However, it also raised the question of what happens when these 
drug companies engage in deceptive marketing tactics and the warnings are not 
considered adequate.137 The Ohio Supreme Court has yet to address an issue as to what 
should happen when the warnings provided to the ‘learned intermediary’ are 
inadequate. As shown by Attorney General DeWine, these pharmaceutical companies 
have not been honest and forthcoming about the side effects that can, and almost 
certainly will, arise from the long-term use of these prescription drugs.138 This is where 
the need for accountability comes. An exception to the Learned Intermediary Doctrine 
is needed because there were not adequate warnings being provided, and it has since 
led to a nationwide epidemic.139 
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III. ANALYSIS 
As the heroin epidemic continues to surge throughout the country, and specifically 
in Ohio, the steps being taken by the government need to be more aggressive and 
serious. Reaching agreements with drug pharmaceutical companies and allowing them 
to pay only a fine, without requiring them to do something in return, is not enough.140 
As shown by the past, these pharmaceutical companies have entered into settlements 
more than once but have still continued their deceptive practices.141 The Learned 
Intermediary Doctrine is being used to allow drug manufacturing companies to 
absolve liability and place all of their liability on physicians.142 To slow the epidemic, 
there needs to be a way for states to hold the drug manufacturing companies liable. 
Drug manufacturing companies are the main source of information regarding the 
opioid drugs that the medical community is prescribing.143 But, these same drug 
manufacturing companies are also the primary source of funding for the CME 
conferences as well as medical journals that were established and sent around for 
physicians to spread information.144 Now, in recognizing that there is a problem by 
allowing these companies to fund everything, independent sources are coming forward 
to do so as well as doctors’ offices and hospitals. They are agreeing to step away from 
such close interactions with these companies.145  
While this idea has been prompted in many states, the biggest question that arises 
is, “who is going to pay for these continuing education programs?”146 The next 
question is, “why should tax payers be responsible for any charges brought where 
these drug manufacturing companies have been using misleading and deceptive 
schemes in order for them to make more money?” Among many settlement talks 
happening surrounding several hundred opioid lawsuits, Federal Judge Dan Polster is 
suggesting that the money from these settlements goes toward treatment for 
individuals who have already been affected by this and to have doctors educated on 
the effects of these drugs and ways to prescribe fewer of them.147 While these 
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settlement talks currently do not involve Ohio’s lawsuit versus the five big drug 
companies, it would include several lawsuits that have been brought by cities and 
municipalities in Ohio and involve the settlement money to be distributed in hopes of 
helping people who are currently being affected by this epidemic.148 
A. The Solution: An Exception to the Learned Intermediary Doctrine 
This epidemic is so widespread that it is time for something constructive to be 
done.149 It is time to hold the correct people accountable, open up the ability to slow it 
down, and get these severe issues under control. The reason this solution is the best is 
because it goes to the root of the problem. The drug companies are responsible for 
producing and making the drugs available to physicians as well as to consumers.150 If 
the deceptive marketing strategies are the same, it is going to be the sole responsibility 
of the physicians to ensure that what they are being told by the drug representatives is 
credible and in the best interest of the patients.151 Since there have only ever been 
monetary settlements against these drug companies, some form of accountability 
needs to attach to the companies.152 Part of this solution and promoting accountability 
rests in educating the doctors the correct way, without the influence of the drug 
companies, and encouraging safe practices in writing and delivering prescriptions. 
Many states, including Ohio, have been reluctant to bring such a suit because it is 
considered such a stretch to hold these companies liable, due to the Learned 
Intermediary Doctrine. 
This Note proposes that an exception to the Learned Intermediary Doctrine should 
be introduced. Since the doctrine was originally established through case law, any 
exceptions or abolishment of the doctrine will be able to be effectuated through case 
law as well. Therefore, it is left up to the courts to settle this matter based on law suits 
that are brought revolving around this issue. 
This exception will include two prongs. The first prong will address whether a 
drug manufacturing company is going to try and absolve itself from a duty owed to 
consumers through the Learned Intermediary Doctrine. If the company should want to 
use this, then they must be required to prove that they have done everything in their 
power to stop the drugs from going to the black market. As stated earlier, diversion to 
the black market is most common at the patient level.153 Without providing the 
information that is necessary to the medical community that is responsible for writing 
these prescriptions, it can cause an influx of prescriptions, which then leads to these 
drugs showing up on the black market.154 When the drug manufacturing companies 
are providing information to the medical community that these drugs are safe for long-
term use, without leading to addiction, it can lead to the over-prescription of pain 
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medication under the belief that it is safe to do so.155 By enforcing this prong of the 
exception, it will ensure that doctors are aware of their prescribing habits and are being 
much more conscious to that respect because the information is being provided to them 
directly from the drug representatives and the drug manufacturing companies. 
Under this first requirement, this Note proposes that the duty should rest with the 
drug manufacturers to provide information to the prescribing medical community on 
how to responsibly prescribe opioids. The duty of a drug manufacturer cannot be 
absolved if the information that is provided is knowingly wrong. Under this proposal, 
the standard applied would be that of strict liability. For example, if the drug 
manufacturing company is found to have been providing false or misleading 
information, whether intentionally or not, they will not be able to utilize the Learned 
Intermediary Doctrine as a defense. This will provide an another incentive to ensure 
that the drug manufacturing companies are doing all that they can to conduct research, 
educate, and inform their drug representatives and the medical community.  
A second prong of this exception will include the requirement that drug 
manufacturing companies fund continuing education programs for the medical 
community to whom they provide information. Since the medical community that is 
in charge of prescribing these opioid pain pills is relying on the information provided 
from the manufacturers and their representatives, the only way to absolve the 
manufacturer’s duty entirely is to provide another outlet for education. Part of this 
education plan will be to include education for dealing with chronic pain and pain 
management without the prescription of opioid pain killers. However, the 
pharmaceutical companies will be required to bring in independent speakers, so as to 
ensure they are not giving biased information.156 As previously discussed, when the 
pharmaceutical companies are bringing in their own KOLs, they are able to pay these 
doctors as well as provide them with the information they want to be given out to 
doctors.157 This is further problematic because it gives an incentive for these doctors 
to state opinions based on the amount of money they are being paid instead of what is 
actually safe for the medical community and their patients.158 
If both of these prongs are adopted and accepted on a federal level as well as in the 
state of Ohio, this will be the first of many successful steps towards effectively fighting 
this epidemic.  
While some may make the argument that you cannot completely eradicate drug 
sales on the black market, my first prong would significantly decrease the diversion 
because the drug companies and the medical community would be working together. 
In previous years, it has been the drug companies providing information to the medical 
community and the medical community acting in unison with that information.159 
However, with my first prong being implemented, it would promote true and correct 
information as well as information that is in the best interest of the patients.  
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B. The United States Supreme Court has the Authority to Make this Exception 
Under federal law, the Learned Intermediary Doctrine provides the same defense 
to liability that it does under Ohio law. A prescription drug manufacturer does not 
have a legal duty to warn a consumer of the dangers of a drug as long as adequate 
warning has been provided to the physician.160 Since the Supreme Court established 
this doctrine under case law, the ability to abolish the doctrine or make changes to it 
is also rests within the courts.  
However, the Supreme Court has created several exceptions to this doctrine. 
Specifically, the Court created an exception in Edwards v. Basel Pharmaceuticals, a 
case where a man had a heart attack when he was wearing two nicotine patches.161 The 
widow of the man sued the pharmaceutical company that manufactured the nicotine 
patch under products liability law.162 The court in this case held that the Learned 
Intermediary Doctrine did not apply because the manufacturers were required to 
provide certain warnings to consumers of certain products.163 The court further stated 
that, the learned-intermediary doctrine should not be used to preclude liability, even if 
the manufacturer had provided adequate warnings to the physician.164 This ruling by 
the Supreme Court should reflect overall rulings in products liability cases. If a drug 
is believed to be one that carries such dangerous side effects that it requires the 
manufacturer to ensure adequate warning has been given to the consumer, then the 
manufacturing company should not be able to absolve liability by only providing 
adequate warning to doctors.  
C. The Role of the FDA 
The FDA could also be responsible for allowing any changes to be made to the  
doctrine. Since the FDA is the federal agency charged with consumer protection, 
it is the front runner to be able to establish regulations for prescribing as well as 
manufacturing prescription pain pills.165 The FDA decides whether certain products 
that will be used by consumers are safe for consumption and if any further regulation 
needs to be created once the products are approved.166 If the FDA enforced a regulation 
on drug manufacturers that mandated the manufacturers to go further than just 
providing adequate warnings to the physicians, then that would eliminate the Learned 
Intermediary Doctrine altogether in these instances. 
The FDA requires manufacturers of nicotine patches and/or nicotine gum to 
provide adequate warnings not only to physicians but also to the consumers that will 
be consuming the products.167 If this were to be applied to prescription drug 
manufacturers as well, then the drug manufacturers would be responsible for 
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providing adequate warnings to consumers that could possibly be prescribed these 
prescription drugs as well as the physicians that would be prescribing them. If this 
were to be implemented, it would lead to a decrease in the number of drug related 
deaths. While it may not happen overnight, and could take some time to develop, it is 
ultimately encouraging and would result in a cost-benefit analysis that would come 
out on the side of the consumer. This is what the FDA is charged with doing as the 
only and oldest consumer protection agency within the United States Federal 
Government.  
D. The Ohio Supreme Court has the Authority to Make this Exception 
The Ohio Supreme Court has made several adjustments to the overall application 
of the Learned Intermediary Doctrine.168 One exception, which is especially applicable 
here, gives the defendant a chance to rebut the presumption of inadequate warning.169 
If the drug company can show that an adequate warning would not have made any 
difference in how the physician decides to prescribe a drug, then proximate cause 
cannot be met.170 In this case, the drug company will be absolved of liability for being 
able to show that whether or not there was adequate warning given, it would have 
made no difference.171 The case that set out this exception is different from the current 
Ohio lawsuit because the physicians were being told that there was no long-term 
addiction consequences for prescribing these pain pills for chronic pain.172 If these 
physicians were aware of the addictive nature and the potential for addiction at the 
time, it is a likely conclusion that they would have done things differently. 
This is another way of showing how the Ohio Learned Intermediary Doctrine has 
been expanded. Specifically, here, if the manufacturers are able to show the physicians 
would not have done anything different, then the doctrine can apply. However, if they 
are not able to do so, then the Learned Intermediary Doctrine should not apply, unless 
the manufacturers are willing to accept responsibility by providing funding for CME’s 
for physicians and taking the extra steps to ensure the physicians are properly and 
adequately given information. 
Another exception, in Vaccariello v. Smith & Nephew Richards Inc., the Ohio 
Supreme Court expanded the Learned Intermediary Doctrine to include medical 
devices as well as prescription drugs.173 The court reasoned that while the statute 
specifically defines “ethical drug” and “ethical medical device” separately, there is no 
indication based on the language of the doctrine itself, and it cannot apply to 
prescription medical devices.174 This exception, however, was mainly an expansion of 
the doctrine in favor of the drug companies, but the Ohio Supreme Court did not 
extend any procedural protections as this note is suggesting. Even though the doctrine 
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was expanded here, it was not in a substantive way, and therefore, the court could and 
should still carve out the exception that this Note proposes.  
In order to allow this solution, the Ohio Supreme Court would again have to find 
that an exception is warranted. The court has expanded the Learned Intermediary 
Doctrine and would be able to do so here because it is within the same scope of the 
language. The court should expand the doctrine to include the exception that while the 
drug may not be considered defective, in order for the learned intermediary doctrine 
to apply, the manufacturer must have to show the steps they took.175  
1. Repealing The Learned Intermediary Doctrine 
One possible counter argument to this proposed solution is: rather than creating an 
exception to the learned intermediary doctrine, it could be repealed entirely. This 
argument has been addressed but has not been accepted in jurisdictions nationwide, as 
they all still follow and apply the Learned Intermediary Doctrine.176 
The rebuttal to this argument is the fact that this doctrine under products liability 
law has been recognized nationwide, as well as on a state by state basis.177 Every state 
has some form of the Learned Intermediary Doctrine under their products liability 
law.178 Due to its extensive history, repealing this doctrine would be very difficult. 
The Learned Intermediary Doctrine is also centered in protecting those manufacturers 
who do in fact provide adequate warnings to consumers, as well as physicians, but 
somewhere in the chain of communication, something is lost. It is not a bad doctrine 
that needs to be repealed, but simply needs to be applied in a way that is ensuring the 
right companies are being held liable and the right companies are being absolved of 
liability. While this argument certainly makes sense given the context of this Note, 
this would not be as successful because of the extensive legislative history given to 
this doctrine and acceptance throughout the United States. 
Another reason that appealing this doctrine would not be effective is because of 
the new Direct to Consumer advertising (“DTC advertising”). DTC advertising is an 
up and coming form of advertising that eliminates the need to warn physicians, which 
would eliminate the need for the learned intermediary doctrine altogether.179  
2. Punishment this Late would be Ineffective  
Presumably, drug manufacturers might say that they should not be punished at this 
point because the damage has already been done. Without any further negative acts 
continuing to add to the problem, what is punishing them going to do? Also, it has 
already been shown that at least one of the pharmaceutical companies involved in 
Ohio’s lawsuit and several of the other state lawsuits, Purdue Pharma, has made 
settlements with the federal government.180 Purdue Pharma has also put a drug onto 
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the market that is less-addictive than Oxycodone and has the same effect as far as pain 
relief.181 
Although these companies have already created the danger and it is living out in 
society as we speak, there has yet to be a response from them.182 While it is also in the 
hands of the physicians and the medical community who prescribe these opioid pain 
pills, in holding the drug companies liable for deceptive practices, it will force them 
to act in a positive way. It will require them to ensure that the physicians and the 
medical community they are in fact contacting are not prescribing in a way to allow 
excess pills to end up on the streets or in the hands of addicts.183 It will ensure that if 
these physicians are to be held responsible and the duty falls to them, they are being 
provided the adequate and correct information about what the effects of these opioid 
pills have.184 Furthermore, it will ensure that they be provided that information from 
an independent third party.185 Finally, CME programs are very relevant and necessary 
in the medical community, but it is not reasonable to suggest taxpayers bear the burden 
to fix a public health problem when it is caused by these billion dollar companies.186 
IV. CONCLUSION 
There is no doubt that the Country as a whole is suffering from this severe and 
debilitating epidemic. States like Ohio are complicated, deeply intertwined, and 
continuing to get worse, not better. What is very clear within this ongoing epidemic, 
is that something more needs to be done, and it needs to be sooner rather than later. 
When large pharmaceutical companies are preying on consumers and their physicians 
through deceptive tactics187 and they are able to avoid the blame for their actions,188 
there needs to be consequences. These deceptive marketing practices not only led to 
the opioid epidemic but have also been the background for rapidly increasing the 
seriousness of the epidemic. This Note has discussed the ways that have already been 
proposed, from allowing Narcan to be carried and bringing awareness to the epidemic. 
Even after these proposals have been implemented though, they are still not successful 
in stopping or even decreasing the amount of deaths from overdoses we are seeing 
each and every year. With several states now realizing that the drug pharmaceutical 
companies are at the core of this problem, more and more states are bringing law suits 
against them in an attempt to hold them accountable.  
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Since the learned intermediary doctrine was established through case law,189 any 
changes that can be made to it can be established through case law. This means that 
exceptions can be carved out through case law under the United States Supreme 
Court190 and the Ohio Supreme Court.191 Also, because the Food and Drug 
Administration is tasked with providing consumer protection, regulations could be laid 
out that require drug manufacturers to warn consumers when there are specific drugs 
that are being tested. Further, the FDA could establish the requirement that if the 
warnings are not provided to the consumer, then the drug manufacturing company 
could and will be held liable for any damages that result. 
The answer to decreasing this serious drug epidemic across the nation is to hold 
the pharmaceutical companies accountable and to not allow them to misplace the 
blame. In making these companies understand the capacity of their deceptive 
marketing to doctors and in turn to consumers, they will be forced to make changes 
and to start to remedy their bad practices. This Note proposes a solution that would 
require two separate actions from any company trying to use the Learned Intermediary 
Doctrine. The first prong addresses when a drug manufacturing company is going to 
try and absolve itself from a duty owed to consumers through the learned intermediary 
doctrine. If the company should want to use this, then they must be required to prove 
that they have done everything in their power to stop the drugs from going to the black 
market. The black market is a hot spot for drug addicts to get their hands on drugs 
illegally, and part of the reason behind this is due to the influx of illegal prescription 
drugs into the black market. By ensuring proper prescription methods through giving 
the physicians the information and knowledge they need, it is ensuring that less drugs 
will illegally end up being sold on the black market and ultimately falling into the 
wrong hands. 
The second prong of this exception will include the requirement that drug 
manufacturing companies fund continuing education programs for the medical 
community to whom they provide the information. Since the medical community that 
is in charge of prescribing these opioid pain pills is relying on the information provided 
from the manufacturers and their representatives, the only way to absolve the 
manufacturer’s duty entirely is to provide another outlet for education, instead of 
allowing for the KOLs, which are paid for and provided by the manufacturing 
companies themselves. This will ensure unbiased information as well as correct 
information. Further, this will ensure that the consumer’s best interests are always the 
first consideration. 
It is never too late for a solution, and this would be a strong push in the direction 
of showing the care for the consumers whose lives have been flipped upside down 
because of the deceptive tactics. There needs to be a collective effort across all actors 
involved in order to bring this to an end. Lives are being taken across all age ranges, 
races, income levels, cities and rural areas, without any discrimination, and something 
needs to be done. The proposals set out in this Note will begin to put an end to the 
epidemic and be a giant step in the right direction toward slowing and ultimately 
ending this awful epidemic. 
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